FDA Investigator Gerald Mierle

Gerald Mierle has inspections in 8 countries as of 16 Oct 2023. Gerald Mierle has collaborated with a combinined 2687 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
246
Last Inspection Date:
16 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100009396
Country:
United States of America, Switzerland, India, Germany, Croatia, Netherlands, Spain
Co-Investigator(s):
Abby Lmozeke Baker, Amanda B Athey, Amy A Johnson, Amy C Amaro, Ana P Barido, Ana S Cabrera, Andrea A Branche, Andria L Kuhlman, Anna M Brannen, Arindam Dasgupta, PhD, Barbara A Burke, Barbara A Gullick, Barbara A Rusin, Barbara J Holladay, Barbara M Frazier, Beatrice Greenberg, Billingsley, Brandi N Mcgrady, Brandon L Mariner, Brentley S Collins, Brian A Graves, Brian M Palermo, Brian R Yaun, Brian S Lynch, Bromley, Brooke K Higgins, Bryan J Love, Candice C Mandera, Carrie L Doupnik, CDR Rochelle B Young, RPh, MSA, Charlean R Butler, Charles D Boison, Charlotte E Wilkins, Christine M O'leary, Courtney N Long, Cynthia A Harris, MD, RN, David L Chon, David R Heiar, Dawn C Olenjack, Decarlos A Gomez, Dellarese L Herbert, Dennis L Doupnik, Dennis R Hudson, Dianne H Milazzo, Dirk L Lincoln, Donna D Gallien, MPH, Douglas A Campbell, Douglas Florentino, Dr. Sriram Subramaniam, PhD, Elizabeth A Laudig, Emmanuel A Dimaano, Jr, Esaw, Esra Toussaint, Esther A Ofori, Gail L Katz, Gajendiran Mahadevan, PhD, Gale L Glinecki, Gerald D Bromley, Jr, Gerald March, Gerald Mark, Gifford Whitehurst, Jr, Hamilton, Helen B Ricalde, Ingrid Y Johnson, James W Leonette, Jennifer L Jager, Jennifer L Sheehan, Joan A Loreng, Joey C West, John A Gonzalez, John A Iwen, Johnson, Jose R Hernandez, Ka L Wong, Karen Gale Sego, Karen M Bryerton, Karen M Cooper, Karen S Anthony, Kelley L Clark, Kenneth L Smalls, Kirtida Patel, Krista N Flores, La Tasha M Gunter, Laurianne M Montonye, Laurie A Haxel, Laurie P Norwood, Laurissa S Flowers, LCDR Wilfred A Darang, Lequita M Mayhew, Linda K Weir, Linda R Kuchenthal, Linda S Mattingly, Lisa M Althar, Lori A Holmquist, Lori S Lawless, Louis G An, LT John M Mastalski, Luis A Carrion, Maira P Brading, Marc S Neubauer, Margaret Torres Vazquez, Marion W Nadeau, Marla A Cassidy, Marlene L Davis, Mary Alice Papdimitriou, Mary K Leslie, Mary T Carden, Matthew J Gretkierewicz, Matthew R Mcnew, Melissa D Kalik, Melkamu Getie Kebtie, PhD, Michele M Falchek, Monique S Frazier, Nancy L Meade, Nancy L Neiger, Natasha A Dezinna, Nicholas M Smith, Nicola M Fenty Stewart, Normica G Facey, Patricia A Morrow, Paula J Bretz, Pelekakis, Peter R Lenahan, Randy L Clarida, Richard J Bashay, Robert C Steyert, Robert S Sweeton, Ronald T Nowalk, Ronnie E Jackson, Scott M Esser, Sean R Moynihan, MPH, Shelley H Beausoleil, Sherry L Secrist, BLT DO, Shusheen A Alexander, Slatten, State Agency, Stephen C Eason, Susan M Miller, Sylvia R Dooling, Tamara N Champion, Tamika E Allen, RN, Tania E Vizcaino, Tania Y Hall, Terrance L Thomas, Thomas, Thomas J Hudson, Tiki J Dixon, Vien Q Le, Wanda Y Honeyblue, William D Bassett, Jr, William F Lagud, Jr, William H Linkroum

Gerald Mierle's Documents

Publish Date Document Type Title
December, 2004 FDA 483 Biotest Pharmaceuticals Corporation - Form 483, 2004-12-10
September, 2000 FDA 483 NIH Clinical Center - Form 483, 2000-09-08
October, 2002 FDA 483 LifeNet Health - Form 483, 2002-10-11
July, 2000 FDA 483 American Red Cross Norfolk Main Site - Form 483, 2000-07-06
January, 2003 EIR LifeNet Health - EIR, 2003-01-09
August, 2002 EIR Old Dominion Eye Foundation, Inc. - EIR, 2002-08-05
September, 2004 EIR LifeNet - EIR, 2004-10-11
May, 2003 FDA 483 LifeNet Health - Form 483, 2003-05-06
May, 2003 FDA 483 Response LifeNet Health - Form 483R, 2003-05-30
May, 2003 EIR LifeNet Health - EIR, 2003-06-26
September, 2001 FDA 483 Aventis Bio-Services Inc - Form 483, 2001-09-12
August, 2000 EIR LifeNet Health - EIR, 2000-08-03
January, 2000 FDA 483 LifeNet Health - Form 483, 2000-01-07
September, 2001 EIR Aventis Bio-Services Inc - EIR, 2001-09-12
April, 2000 FDA 483 American Red Cross Blood Services Appalachian Region - Form 483, 2000-04-20
March, 2003 FDA 483 Old Dominion Eye Foundation, Inc. - Form 483, 2003-03-07
August, 2002 FDA 483 Response Old Dominion Eye Foundation, Inc. - Form 483R, 2002-08-28
October, 2004 EIR LifeNet Health - EIR, 2005-03-15
March, 2003 FDA 483 Response Old Dominion Eye Foundation, Inc. - Form 483R, 2003-03-21
January, 2000 EIR LifeNet Health - EIR, 2000-01-07
October, 2002 EIR LifeNet Health - EIR, 2002-10-11
March, 2002 FDA 483 Grifols Biomat USA, Inc. - Form 483, 2002-03-20
March, 2003 EIR Old Dominion Eye Foundation, Inc. - EIR, 2003-03-07
August, 2002 FDA 483 Old Dominion Eye Foundation, Inc. - Form 483, 2002-08-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more